« Back to Record
Remon, J., Menis, J., Hasan, B., Peric, A., De Maio, E., Novello, S., Reck, M., Berghmans, T., Wasag, B., Besse, B., & Dziadziuszko, R. (2017). The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613. Clinical lung cancer, 18(5), 583-588. doi:10.1016/j.cllc.2017.02.005
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/256733



